Evommune Share Price

Evommune Share Price

NYSE: EVMN | Micro Cap | Healthcare
$7.22
+$0.32 (4.64%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Evommune Stock Performance

Open
$7.13
Prev. Close
$6.90
Circuit Range
N/A
Day Range
$6.95 - $7.38
Year Range
$4.94 - $33.08
Volume
30,561
Average Traded
$7.13

Evommune Share Price Today

As of 20 November 2026, Evommune, Inc.'s share price is $7.22. The stock opened at $7.13, compared to its previous close of $6.90. During today's trading session, Evommune, Inc.'s share price traded between $6.95 and $7.38, with an average price of $7.17. Over the past 52 weeks, the stock has recorded a high of $33.08 and a low of $4.94. In terms of performance, Evommune, Inc.'s share price has declined by 68.89% over the last six months and is down 64.48% on a year-on-year basis.

Evommune Share Price Chart

Line chart of the Evommune price trend over the selected period. The price rose overall, ranging from 6.78 to 7.21, ending at 6.90.
$6.95$7.38
L
Show Current Price
H

Evommune Stock Fundamentals & Key Indicators

Market Cap
$44.31M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.73
Revenue (TTM)
$13.00B
Return On Equity (TTM)
-44.98%
Profit Margin
-529.77%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-9.23%

Evommune Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$28.27-$21.67-$32.25-$30.88
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A23.35%-48.82%4.25%

Evommune Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$13.00
Net Profit-$68.87
Net Profit Margin-529.77%
Income ChangeN/A

Evommune Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets71.47
Current Assets153.48
Total Assets224.95
Non Current Liabilities1.47
Current Liabilities17.91
Total Liabilities19.38
Shareholders' Equity205.57

Evommune Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-76.44
Investing-115.31
Financing220.76

About Evommune

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Evommune Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.67
$7.23
+7.75%
Oct 2026
$8.18
$6.71
-18.37%
Sep 2026
$12.54
$8.22
-38.88%
Aug 2026
$11.17
$13.45
+19.66%
Jul 2026
$13.30
$11.24
-15.36%
Jun 2026
$22.98
$13.28
-42.78%
May 2026
$23.60
$23.21
-2.09%
Apr 2026
$24.57
$23.70
+3.07%
Mar 2026
$25.70
$23.00
-11.93%
Feb 2026
$18.66
$26.11
+44.84%
Jan 2026
$17.64
$18.03
+5.38%
Dec 2025
$22.64
$17.11
-15.82%

Evommune Share Price FAQs